Angela M Cacace
Chief Scientific Officer at Arvinas, Inc. (ARVN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $214K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 18SEC | ARVNArvinas, Inc. | Sell Plan | 2,576180,390 held (−1%) | $7.60 | $20K | +0.5% |
| May 13SEC | ARVNArvinas, Inc. | Sell | 9,657182,966 held (−5%) | $9.94 | $96K | -23.1% |
| Feb 25SEC | ARVNArvinas, Inc. | Sell | 1,038150,194 held (−1%) | $12.16 | $13K | -37.2% |
| Feb 25SEC | ARVNArvinas, Inc. | Sell | 2,571147,623 held (−2%) | $12.16 | $31K | -37.2% |
| Feb 18SEC | ARVNArvinas, Inc. | Sell | 4,592151,232 held (−3%) | $11.89 | $55K | -35.7% |
- Sell
Chief Scientific Officer Angela M Cacace sold $20K of ARVN at $7.60 — pre-scheduled 10b5-1 plan sale.